AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

计划入组 1,250 人 · 首次发布于 2021 年 3 月 19 日

Psilocybin to Treat Depression in Spinal Cord Injury

计划入组 30 人 · 首次发布于 2025 年 11 月 26 日

Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life

计划入组 50 人 · 首次发布于 2026 年 7 月 22 日

Urokinase plasminogen activator (Baker IDI Heart & Diabetes Institute/University of Melbourne)

VCP-979

Diabetes(Dewpoint)

DASMAN DIABETES INSTITUTE

Kuwait

International Diabetes Institute

Australia

Sansum Diabetes Research Institute

United States

FDA Approves Ozempic for Reducing Kidney Disease Risks in Type 2 Diabetes Patients

Semaglutide Reduces Kidney Disease Risk by 24% in Landmark FLOW Trial for Type 2 Diabetes Patients

Tirzepatide Demonstrates Cardiovascular Benefits in Type 2 Diabetes Patients with ASCVD and OSA